Verici Dx – interims, was the fundraise for accelerated progress or to avert cash crunch ahoy?
Previously writing on transplant platform company Verici Dx (VRCI), in June with the shares down to 26p I questioned was the “fundraise to… continue the accelerated progress” or to avert cash crunch ahoy?. Now half-year results... and the shares currently further down to 17.5p.
- By Steve Moore
- 2022-09-07 11:30:53